A low initial botulinum toxin A treatment response does not predict poor long-term outcomes in patients with axillary bromhidrosis

2017 ◽  
Vol 29 (1) ◽  
pp. 102-104 ◽  
Author(s):  
Jinguang He ◽  
Tao Wang ◽  
Jiasheng Dong
2016 ◽  
Vol 9 (1) ◽  
pp. 3-10 ◽  
Author(s):  
David Eldred-Evans ◽  
Arun Sahai

Botulinum toxin A (BoNT-A) has become an important therapeutic tool in the management of refractory overactive bladder (OAB). Over the last decade, there have been growing numbers of patients receiving repeat injections and these outcomes have begun to be reported in large, high-quality cohorts. This article reviews the current evidence for the medium- to long-term use of BoNT-A in adults with idiopathic detrusor overactivity (IDO) receiving repeat injections. We find that medium-term outcomes are encouraging but long-term outcomes are not as extensively reported. There is high-quality evidence that efficacy following the first injection persists across multiple treatment cycles. There are no additional safety concerns from repeat injections up to six treatment cycles. However, there is a need for further data to confirm the efficacy and safety of BoNT-A beyond the follow-up period in the current literature.


2008 ◽  
Vol 35 (S 01) ◽  
Author(s):  
K Kollewe ◽  
S Baloush ◽  
K Krampfl ◽  
H Bigalke ◽  
R Dengler ◽  
...  

2002 ◽  
Vol 17 (6) ◽  
pp. 1288-1293 ◽  
Author(s):  
G-Y.R. Hsiung ◽  
S.K. Das ◽  
R. Ranawaya ◽  
A.-L. Lafontaine ◽  
O. Suchowersky

2021 ◽  
Vol 429 ◽  
pp. 119548
Author(s):  
Luca Bosco ◽  
Carla Butera ◽  
Giacomo Sferruzza ◽  
Stefano Amadio ◽  
Roberta Guerriero ◽  
...  

2020 ◽  
Vol 42 (5) ◽  
pp. 400-408
Author(s):  
M. Trzpis ◽  
J. M. Klaase ◽  
R. H. Koop ◽  
P. M. A. Broens

Abstract Background Several studies have investigated the short- and long-term efficacy of fissurectomy combined with botulinum toxin A injection for patients with chronic anal fissure. Objective To evaluate the short- and long-term efficacy of the combined treatment strategy of fissurectomy with botulinum toxin A for chronic anal fissure and to discuss recurrence rates in the light of current theory on the aetiology of anal fissure. Materials and methods This is a narrative review. We conducted an article search using PubMed and calculated the means of the reported efficacy ranges. Results Fissurectomy combined with botulinum toxin A injections freed at least 78% of the patients from symptoms and yielded a fissure healing rate of up to 86%. Within 12 months after treatment a 3% recurrence rate was reported. On average, the long-term recurrence rate was 22%. One study reported a 50% recurrence rate 22 months after treatment. Conclusion The efficacy of fissurectomy combined with botulinum toxin A injection for chronic anal fissure is high. The short-term recurrence rate is low, while long-term recurrence is relatively high. Extended follow-up indicates that recurrence of chronic anal fissure is possibly caused by anal basal pressure building up steadily once again. If so, the cause of renewed increase of pressure should be addressed. Based on the literature and on our clinical experience, we assume that the underlying cause of increasing anal basal pressure is that patients use their pelvic floor muscles inadequately and this in turn leads to chronic anal fissure.


Toxicon ◽  
2015 ◽  
Vol 107 ◽  
pp. 129-140 ◽  
Author(s):  
Martina Petracca ◽  
Arianna Guidubaldi ◽  
Lucia Ricciardi ◽  
Tàmara Ialongo ◽  
Alessandra Del Grande ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document